The trajectory of Sildenafil presents a intricate picture for those considering investment. While the initial introduction generated significant profits, the end of its patent opened the floodgates to generic versions, https://dftsocial.com/story22761284/sildenafil-and-the-pharmaceutical-industry-a-precarious-investment